Antiplasmodial chalcones inhibit sorbitol-induced hemolysis of Plasmodium falciparum-infected erythrocytes

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 9, 2004, Pages 3241-3245

  Go, Mei Lin ^a   Liu, Mei ^a   Wilairat, Prapon ^b   Rosenthal, Philip J ^c   Saliba, Kevin J ^d   Kirk, Kiaran ^d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHALCONE DERIVATIVE; SORBITOL;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; ERYTHROCYTE MEMBRANE; HEMOLYSIS; HUMAN; HUMAN CELL; HYDROXYLATION; IC 50; LIPOPHILICITY; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIMALARIALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHALCONE; CHEMISTRY, PHYSICAL; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; HEMOLYSIS; HUMANS; MALARIA; PLASMODIUM FALCIPARUM; SORBITOL; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 4344668584     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.9.3241-3245.2004     Document Type: Article

References (25)

1. Alley, M. C., D. A. Scudiero, A. Monks, M. L. Hursey, M. J. Czerwinski, D. L. Fine, B. J. Abbott, J. G. Mayo, R. H. Shoemaker, and M. R. Boyd. 1988. Feasibility of drug screening with panels of human tumour cell lines using a microculture tetrazolium assay. Cancer Res. 48:589-601.
2. Angerhofer, C. K., H. Guinaudeau, V. Wongpanich, J. M. Pezzuto, and G. A. Cordell. 1999. Antiplasmodial and cytotoxic activity of natural bisbenzyl-isoquinoline alkaloids. J. Nat. Prod. 62:59-66.
3. Cabantchik, Z. I. 1990. Properties of permeation pathways induced in the human red cell membrane by malaria parasites. Blood Cells 16:421-432.
4. Chen, M., T. G. Theander, S. B. Christensen, L. Hviid, L. Zhai, and A. Kharazmi. 1994. Licochalcone A, a new antimalarial agent inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection. Antimicrob. Agents Chemother. 38:1470-1475.
5. Chen, M., L. Zhai, S. B. Christensen, T. G. Theander, and A. Kharazmi. 2001. Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones. Antimicrob. Agents Chemother. 45:2023-2029.
6. + exclusion. Mol. Biochem. Parasitol. 132:27-34.
7. Dominguez, J. N., J. E. Charris, G. Lobo, N. G. de Dominquez, M. M. Moreno, F. Riggione, E. Sanchez, J. Olson, and P. J. Rosenthal. 2001. Synthesis of quinolinyl chalcones and evaluation of their antimalarial activity. Eur. J. Med. Chem. 36:555-560.
8. Gero, A. M., and A. L. Weis. 2001. Development of new malaria chemotherapy by utilization of parasite-induced transport, p. 367-384. In P. J. Rosenthal (ed.), Antimalarial chemotherapy: mechanisms of action, resistance and new directions in drug discovery. Humana Press, Totowa, N.J.
9. Ginsburg, H., S. Kutner, M. Krugliak, and Z. I. Cabantchik. 1985. Characterization of permeation pathways appearing in the host membrane of Plasmodium falciparum infected red blood cells. Mol. Biochem. Parasitol. 14:313-322.
10. Kanaani, J., and H. Ginsburg. 1992. Effects of cinnamic acid derivatives on in vitro growth of Plasmodium falciparum and on the permeability of the membrane of malaria-infected erythrocytes. Antimicrob. Agents Chemother. 36:1102-1108.
11. Kirk, K. 2001. Membrane transport in the malaria-infected erythrocyte. Physiol. Rev. 81:495-537.
12. Kirk, K., and H. A. Horner. 1995. In search of a selective inhibitor of the induced transport of small solutes in Plasmodium falciparum-infected erythrocytes: effects of arylaminobenzoates. Biochem. J. 311:761-768.
13. Kirk, K., H. A. Horner, B. C. Elford, J. C. Ellory, and C. I. Newbold. 1994. Transport of diverse substrates into malaria-infected erythrocytes via a pathway showing functional characteristics of a chloride channel. J. Biol. Chem. 269:3339-3347.
14. Kirk, K., H. A. Horner, D. J. Spillett, and B. C. Elford. 1993. Glibenclamide and meglitinide block the transport of low molecular weight solutes into malaria-infected erythrocytes. FEBS Lett. 323:123-128.
15. Kutner, S., W. V. Breuer, H. Ginsburg, and Z. I. Cabantchik. 1987. On the mode of action of phlorizin as an antimalarial agent in in vitro cultures of Plasmodium falciparum. Biochem. Pharmacol. 36:123-129.
16. Li, R., X. Chen, B. Gong, P. M. Selzer, Z. Li, E. Davidson, G. Kurzban, R. E. Miller, E. O. Nuzum, J. H. McKerrow, R. J. Fletterick, S. A. Gillmor, C. S. Craik, I. D. Kuntz, F. E. Cohen, and G. L. Kenyon. 1996. Structure-based design of parasitic protease inhibitors. Bioorg. Med. Chem. 9:1421-1427.
17. Liu, M. 2003. Investigations on the antimalarial activity of alkoxylated and hydoxylated chalcones. Ph.D. thesis. National University of Singapore, Singapore, Republic of Singapore.
18. Lui, M., P. Wilairat, S. L. Croft, L. C. A. Tan, and M. L. Go. 2003. Structure-activity relationships of antileishmanial and antimalarial chalcones. Bioorg. Med. Chem. 11:2729-2738.
19. Lui, M., P. Wilairat, and M. L. Go. 2001. Antimalarial alkoxylated and hydroxylated chalcones: structure-activity relationship analysis. J. Med. Chem. 44:4443-4452.
20. Staines, H. M., B. C. Dee, M. O'Brien, H. J. Lang, H. Englert, H. A. Horner, J. C. Ellory, and K. Kirk. 2004. Furosemide analogues as potent inhibitors of the new permeability pathways of Plasmodium falciparum-infected human erythrocytes. Mol. Biochem. Parasitol. 133:315-318.
21. Staines, H. M., C. Rae, and K. Kirk. 2000. Increased permeability of the malaria-infected erythrocytes to organic cations. Biochim. Biophys. Acta 1463:88-98.
22. Upston, J. M., and A. M. Gero. 1995. Parasite-induced permeation of nucleosides in Plasmodium falciparum malaria. Biochim. Biophys. Acta 1236:249-258.
23. Wilkinson, G. R. 2001. Pharmacokinetics: the dynamics of drug absorption, distribution and elimination, p. 3-29. In J. G. Hardman and L. L. Limbard (ed.), Goodman and Gilman's the pharmacological basis of therapeutics, 10th ed. McGraw-Hill, New York, N.Y.
24. Zhai, L., M. Chen, J. Blom, T. G. Theander, S. B. Christensen, and A. Kharazmi. 1999. The antileishmanial activity of novel oxygenated chalcones and their mechanism of action. J. Antimicrob. Chemother. 43:793-803.
25. Zhang, Y., X. Guo, E. Y. Lin, and L. Z. Benet. 1999. In vitro biotransformation of a novel antimalarial cysteine protease inhibitor in human liver microsomes. Pharmacology 58:147-159.